Antihyperlipidemic activity of Commiphora mukul: A review

Disorders of lipoprotein metabolism are collectively referred to as “Dyslipidemias”. Most of the Dyslipidemias are Hyperlipidemias Cardiovascular disease is the leading cause of morbidity and mortality world-wide, which is an important risk factor for cardiovascular diseases. Therapies aimed at lipid modification are important for the reduction of cardiovascular risk. Pharmacological management in conventional medicine includes statins and fibrates or both. The statins and fibrates have side effects such as myalgia, myositis, rhabdomyolysis, dyspepsia, renal failure and cholelithiasis etc. In Unani medicine a large number of single and compound drugs are being used in the treatment of Obesity. Experimental and clinical studies of some of these drugs revealed hypolipidemic, antioxidant and cardioprotective properties This review discusses the antihyperlipidemic activities of the Commiphora mukul.